srpt gene therapy - Search News

Order byBest matchMost fresh

FDA asks Sarepta to stop shipping gene therapy

Exclusive: US FDA to ask Sarepta to stop shipments of gene therapy Elevidys, source says

The U.S. Food and Drug Administration is planning to request Sarepta Therapeutics (SRPT.O) to voluntarily stop all shipments of its gene therapy, Elevidys, a source familiar with the matter told Reut...

· 1d

Sarepta's Setback Deepens With Another Gene Therapy Fatality

· 1d · on MSN

Sarepta falls as report suggests FDA weighing a request to stop gene therapy shipments

· 1d

Sarepta Says It Won't Comply With FDA Request to Stop Shipping Gene Therapy Elevidys

Wall Street analysts have said the third death could amplify patient hesitancy to use Elevidys, given both the therapies use the same delivery vehicle known as adeno-associated virus vector.

· 1d

Sarepta Therapeutics crisis is huge blow to Duchenne families, company

· 1d

Exclusive: US FDA to request Sarepta to stop all shipments of gene therapy Elevidys, source says

Sarepta Therapeutics: What's Happening With SRPT Stock?

The favorable market reaction indicates investor relief at management’s swift measures to rectify the company's worsening financial situation.

Seeking Alpha1y

Sarepta: Leading The Way In DMD Treatment With Gene Therapy Innovations ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is a biopharmaceutical company that develops Duchenne muscular dystrophy (DMD) and Limb-girdle muscular dystrophy (LGMD) treatments using gene therapy, RNA ...

Insider Monkey6mon

Sarepta Therapeutics, Inc. (SRPT): Is This Gene Therapy Stock a Good ...

The cornerstone of Sarepta Therapeutics, Inc. (NASDAQ:SRPT)’s recent success has been ELEVIDYS, a gene therapy approved by the FDA in June 2023, and later expanded in 2024 to treat ambulatory ...

Zacks Investment Research on MSN3d

SRPT Stock Soars on Unveiling New Restructuring Plan, Pipeline Pivots

Shares of Sarepta Therapeutics SRPT surged more than 30% in after-market trading yesterday after the company announced a strategic restructuring plan focused on pipeline reprioritization and supporting long-term financial sustainability.